Mitchell Cancer Institute
Decrease (-) Restore Default Increase (+) text size
Print    Email
Related Links
News
Archives
Around the Institute
Media Library
Minds Conquering Cancer - Past Issues
Published Articles
Related links

News

Title
September 26, 2017 - Fan named chief medical physicist for Radiation Oncology
Article

Fan 847.jpg

MOBILE, Ala. -- Jiajin “James” Fan, Ph.D., has been named chief medical physicist and professor of interdisciplinary clinical oncology at USA Mitchell Cancer Institute. He comes to MCI from Fox Chase Cancer Center in Philadelphia, where he was director of medical physics at Virtua Health System and a lead physicist for CyberKnife Stereotactic Radiosurgery. 

At MCI, Dr. Fan will develop treatment plans in MCI’s Radiation Oncology Services department, which brings together several disciplines – physics, radiation oncology and surgery.

A native of China, Dr. Fan earned a Ph.D. in nuclear science and technology and a bachelor of science in engineering physics from Tsinghua University in Beijing.

Dr. Fan says he was attracted to MCI’s overall environment, technology and potential for growth.

“The technology at MCI provides a lot of treatment for patients, but there is also potential for more programs, protocols and patient treatment advancements,” he says. Dr. Fan sees MCI as having the talent and infrastructure to be recognized as a force in oncologic research, innovation and patient care on the national level.

Already, MCI has garnered attention for having the only CyberKnife on the Alabama Gulf Coast.  CyberKnife is a type of robotic radiosurgery system that delivers radiation so precise that it can target a tumor the size of a kernel of popcorn. Patients can avoid the invasiveness of traditional surgery and enjoy a shorter recovery time.

In his role at MCI, Dr. Fan explains that he will “help with all technical parts of treatment machinery” and will serve as a “bridge between patients and machine.” In the long term, Dr. Fan aspires be instrumental in helping MCI build upon its reputation as a leading treatment center for patients in the region and the nation, and enhance research opportunities for patient care. 

“It is exciting to have someone with Dr. Fan’s expertise join the USA MCI family,” said MCI Radiation Oncology Manager Hal Hopper. “Dr. Fan is driven to help the Mitchell Cancer Institute be recognized as the leader in cancer treatment and research in the Gulf Coast region through evaluation and procurement of the latest technologies and procedures.”

Dr. Fan also aims to continue his use of Monte Carlo methods -- a means of problem solving using random sampling to find numerical results. Monte Carlo methods and their clinical applications are among Dr. Fan’s many research interests.  With one patent, 44 peer-reviewed publications, 129 peer-reviewed abstracts, a book chapter and 20 presentations on his resume, Dr. Fan intends to remain active in advancing the field of medical physics. He is passionate about implementing meaningful change at the programmatic level. At Fox Chase, Dr. Fan was instrumental in developing and instituting clinical services from the ground up. 

Dr. Fan says he hopes that his passion for research, cutting-edge innovation, organization and patient care will translate into great happenings at MCI. Among his goals are helping MCI continue its evolution into a widely-known hub for patient care and innovative research.

About MCI: USA Mitchell Cancer Institute is the only academic cancer research and treatment facility on the upper Gulf Coast corridor, with offices in Mobile, Fairhope and Monroeville.

 

 

Footer
Copyright © 2017  USA Mitchell Cancer Institute
Footer